Publicacións en colaboración con investigadores/as de Universidade da Coruña (31)

2023

  1. Single-port retroperitoneoscopic partial nephrectomy: Initial description and standardisation of technique

    Journal of Minimal Access Surgery, Vol. 19, Núm. 2, pp. 278-281

2022

  1. Single-port robot-assisted retroperitoneal surgery: A feasible approach

    Actas Urologicas Espanolas, Vol. 46, Núm. 10, pp. 653-657

2020

  1. Androgen deprivation therapy in patients with localized disease: Comparison with curative intent treatments and time to castration resistance. Results of the Spanish Prostate Cancer Registry

    Actas Urologicas Espanolas, Vol. 44, Núm. 3, pp. 156-163

  2. Manejo del paciente neurourológico durante la pandemia COVID-19

    Archivos espanoles de urologia, Vol. 73, Núm. 5, pp. 429-437

2019

  1. Erectile dysfunction in patients with arterial hypertension. Cardiovascular risk and impact on their quality of life

    Medicina Clinica, Vol. 152, Núm. 6, pp. 209-215

  2. Role of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillance

    Prostate Cancer and Prostatic Diseases, Vol. 22, Núm. 1, pp. 84-90

2018

  1. Mecanismos de resistencia a la castración

    Archivos Espanoles de Urologia, Vol. 71, Núm. 8, pp. 628-638

  2. Safety and efficacy of various strains of bacille Calmette-Guérin in the treatment of bladder tumours in standard clinical practice

    Actas Urologicas Espanolas, Vol. 42, Núm. 4, pp. 238-248

  3. Variability in the multicentre National Registry in Active Surveillance; a questionnaire for urologists

    Actas Urologicas Espanolas, Vol. 42, Núm. 7, pp. 442-449

2017

  1. The management of active surveillance in prostate cancer: Validation of the Canary Prostate Active Surveillance Study risk calculator with the Spanish Urological Association Registry

    Oncotarget, Vol. 8, Núm. 65, pp. 108451-108462

2016

  1. Intermittent versus continuous androgen deprivation therapy in patients with relapsing or locally advanced prostate cancer: A Phase 3b Randomised Study (Iceland)

    European Urology, Vol. 69, Núm. 4, pp. 720-727

  2. Tendencias de tratamiento en el cáncer de próstata clínicamente localizado. Análisis poblacional a nivel nacional: grupo GESCAP

    Actas Urologicas Espanolas, Vol. 40, Núm. 4, pp. 209-216

2015

  1. Clinical characteristics and long-term outcomes of patients undergoing combined heart-kidney transplantation: A single-center experience

    Transplantation Proceedings

  2. Coste evitado en medicamentos de ensayos clínicos en cáncer de próstata

    Actas Urologicas Espanolas, Vol. 39, Núm. 9, pp. 553-557

  3. Prevention of bone metastases in patients with high-risk nonmetastatic prostate cancer treated with zoledronic acid: Efficacy and safety results of the zometa european study (ZEUS)

    European Urology, Vol. 67, Núm. 3, pp. 482-491

  4. Urachal adenocarcinoma of the bladder, our experience in 20 years

    Archivos Espanoles de Urologia, Vol. 68, Núm. 2, pp. 178-182

2014

  1. Focal therapy for prostate cancer. rationale, indications and selection

    Actas Urologicas Espanolas

  2. MicroARN circulantes en sangre de pacientes con cáncer de próstata

    Actas Urologicas Espanolas, Vol. 38, Núm. 10, pp. 633-639

2013

  1. Cáncer de próstata: ¿tratar o no tratar?

    Actas Urologicas Espanolas

  2. Degarelix versus goserelin (+ antiandrogen flare protection) in the relief of lower urinary tract symptoms secondary to prostate cancer: Results from a phase IIIb study (NCT00831233)

    Urologia Internationalis, Vol. 90, Núm. 3, pp. 321-328